Alteration of Gα subunits mRNA levels in bromocriptine resistant prolactinomas

Journal of Neuroendocrinology

Volumn 8, Issue 10, 1996, Pages 737-746

  Caccavelli, L ^a,b,c   Morange Ramos, I ^a   Kordon, C ^b   Jaquet, P ^a   Enjalbert, A ^a,b  

^a AIX MARSEILLE UNIVERSITY   (France)

^b CENTRE PAUL BROCA   (France)

^c UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Bromocriptine resistance; D2 dopamine receptors; G protein expression; Prolactinomas

Indexed keywords

BROMOCRIPTINE; DOPAMINE 2 RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; MESSENGER RNA; PROLACTIN; PROTEIN SUBUNIT;

ADULT; ARTICLE; CLINICAL ARTICLE; DRUG RESISTANCE; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROLACTIN RELEASE; PROLACTINOMA; RECEPTOR DENSITY; RECEPTOR DOWN REGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0029740654     PISSN: 09538194     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2826.1996.04902.x     Document Type: Article

References (40)

1. Enjalbert A, Bockaert J. Pharmacological characterization of the D2 dopamine receptor negatively coupled with adenylate cyclase in rat anterior pituitary. Mol Pharmacol 1982; 23: 576-84.
2. Journot L, Homburger V, Pantalni C, Priam M, Enjalbert A. An islet activating protein-sensitive G protein is involved in dopamine inhibition of angiotensin and thyrotropin-releasing hormonestimulated inositol phosphate production in anterior pituitary cells. J Cell Biol 1987; 262: 15106-15110.
3. Lledo PM, Legendre P, Israel JM, Vincent JD. Dopamine inhibits two characterized voltage-dependent calcium currents in identified rat lactotroph cells. Endocrinol 1990; 127: 990-1001.
4. Lledo PM. Legendre P, Zhang J, Israel JM, Vincent JD. Effects of dopamine in voltage-dependent potassium currents on identified rat lactotroph cells. Neuroendocrinol 1990; 52: 545-555.
5. Bouvier C, Forget H, Lagacé G. et al. G proteins in normal rat pituitaries and in prolactin-secreting rat pituitary tumors. Mol Cell Endocrinol 1991; 78: 33-44.
6. Paulssen EJ, Paulssen RH, Haugen TB, Gautvick KM, Gordeladze JO, Cell specific distribution of guanine nucleotide-binding regulatory proteins in rat pituitary tumor cell lines. Mol Cell Endocrinol 1991; 76: 45-53.
7. Senogles SE, Spiegel AM, Padrell E, lyengar R, Caron MG. Specificity of receptor-G protein interactions; discrimination of Gi subtypes by the D2 dopamine receptor in a reconstituted system. J Biol Chem 1990; 265: 4507-4514.
8. 21 currents in rat anterior pituitary cells. Neuron 1992; 8: 455-463.
9. Baertschi AJ, Audigier Y, Lledo PM et al Dialysis of lactotropes with antisense oligonucleotides assigns guanine nucleotide binding protein subtypes to their channel effectors. Mol Endocrinol 1992; 6: 2257-2265.
10. Thorner MO, Martin WH, Rogol AD et al. Rapid regression of. pituitary prolactinomas during bromocriptine treatment. J Clin End Metab 1980; 51: 438-445,
11. Bergh T, Nillius SJ, Enoksson P, Larsson SG, Wide L. Bromocriptine-induced pregnancies in women with large prolactinomas. Clin Endocrinol 1982; 17: 625-631.
12. Thorner MO, Schran HF, Evans WS et al. Broad spectrum of prolactin suppression by bromocriptine in hyperprolactinemic women: a study of serum prolactin levels after acute and chronic administration of bromocriptine. J Clin End Metab 1980; 50: 1026-1033.
13. Pellegrini I, Rasolonjanahary R, Gunz G et al. Resistance to bromocriptine in prolactinomas. J Clin End Metab 1989; 69: 500-509.
14. Caccavelli L, Féron F, Morange I et al Decreased expression of the two dopamine receptor isoforms in bromocriptine resistant prolactinomas. Neuroendocrinology 1994; 60: 314-322.
15. Friedman E, Adams EF, Höög A et al Normal structural dopamine type 2 receptor gene in prolactin-secreting and other pituitary tumors. J Clin End Metab 1994; 78: 568-574.
16. Collu R, Bouvier C, Lagacé G et al. Selective deficiency of guanine nucleotide-binding protein Go in two dopamine-resistant pituitary tumors. Endocrinology 1988; 122: 1176-1178.
17. Vallar L, Spada A, Giannattasio G. Altered Gs and adenylate cyclase activity in human GH-secreting pituitary adenomas. Nature 1987; 330: 566-568.
18. Landis CA, Masters SB, Spada A et al. GTPase inhibiting mutations activate the αchain of Gs and stimulate adenylyl cyclase in human pituitary tumors. Nature 1989; 340: 692-696.
19. Lyons J, Landis CA, Harsh G et al. Two G protein oncogenes in human endocrine tumors. Science 1990; 249: 655-659.
20. Wong YH, Federman A, Pace AM et al. Mutant α subunits of Gi2 inhibit cyclic AMP accumulation. Nature 1991; 351: 63-65.
21. Gilliland G, Perrin S, Blanchard K, Bunn HF. Analysis of cytokine mRNA and DNA: detection and quantitation by competitive polymerase chain reaction. Proc Natl Acad Sci USA 1990; 87: 2725-2729.
22. Van Gemen B, Kievits T, Schukkink R et al Quantification of HIV-1 RNA in plasma using NASBA ™ during HIV-1 primary infection. J Virol Methods 1993; 43: 177-188.
23. Bray P, Carter A, Simons C et al. Human cDNA clones for four species of GαS signal transduction protein. Biochem 1986; 83: 8893-8897.
24. Mattera R, Codina J, Crozat A et al Identification by molecular cloning of two forms of the a-subunit of the human liver stimulatory (Gs) regulatory component of adenylyl cyclase. FEBS Lett 1986; 206: 36-42.
25. Senogles SE, Spiegel AM, Padrell E, lyengar R, Caron MG. Specificity of receptor-G protein interactions: discrimination of Gi subtypes by the D2 dopamine receptor in a reconstituted system. J Biol Chem 1990; 265: 4507-4514.
26. Guiramand J, Montmayer JP, Ceraline J, Bhatia M, Borreli E. Alternative splicing of the dopamine D2 receptor directs specificity of coupling to G-proteins. J Biol Chem 1995; 270: 7354-7358.
27. Swennen L, Denef C. Physiological concentrations of dopamine decrease adenosine 3',5' monophosphate levels in cultured rat anterior pituitary cells and enriched population of lactotrophs: evidence for a causal relationship to inhibition of prolactin release. Endocrinolology 1982; 111: 398-405.
28. Hsu WH, Rudolph U, Sanford J et al. Molecular cloning of a novel splice variant of the a subunit of the mammalian Go protein. J Biol Chem 1990; 265: 11220-11226.
29. Tsukamoto T, Toyama R. Itoh H et al. Structure of the human gene and two rat cDNAs encoding the α chain of GTP-binding regulatory protein Go: two different mRNAs are generated by alternative splicing. Proc Natl Acad Sci USA 1991; 88: 2974-2978.
30. Man-Son-Hing HJ, Codina J, Abramowitz J, Haydon PG. Microinjection of the α-subunit of the G protein Go2, but not Gol, reduces a voltage-sensitive calcium current. Cell Signalling 1992; 4: 429-441.
31. Granneman JG. Bannon MJ. Splicing pattern of GαS mRNA in human and rat brain. J Neurochem 1991; 57: 1019-1023.
32. O'Donnell JK, Sweet RW, Stadel JM. Expression and characterization of the long and short splice variants of Gsαin S49 cyc- cells. Mol Pharmacol 1991; 39: 702-710.
33. Tang WJ, Oilman AG. Adenylyl cyclases. Cell 1992; 70: 869-872.
34. Tang WJ, Oilman AG. Type-specific regulation of adenylyl cyclase by G protein βγ subunits. Science 1991; 254: 1500-1503.
35. Taussig R, Quarmby LM, Gilman AG. Regulation of purified type I and type II adenylyl-cyclases by G protein βγsubunits. J Biol Chem 1993; 268: 9-12.
36. Federman AD. Conklin BR, Schrader KA, Reed RR, Bourne HR. Hormonal stimulation of adenylyl cyclase through Gi-protein βγ subunits. Nature 1992; 356: 159-161.
37. Wilson BS, Komuro M, Farquhar MG. Cellular variations in heterotrimeric G protein localization and expression in rat pituitary. Endocrinololgy 1994; 134: 233-244.
38. Jaquet P, Gunz G, Grisoli F. Hormonal regulation of prolactin release by human prolactinoma cells cultured in serum-free conditions. Harm Res 1985; 22: 153-163.
39. Maniatis T, Fritsch EF, Sambrook J. Extraction, purification and analysis of messenger RNA from eukariotic cells. In: Ford N, Nolan C, Fergusson M. eds. Molecular Cloning, a Laboratory Manual. Cold Spring Harbor Laboratory, 1982; 7.3-7.26.
40. Wang AM, Doyle MV, Mark DF. Quantitation of mRNA by the polymerase chain reaction. Proc Natl Acad Sci USA 1989; 86: 9717-9721.